About Chromition
Chromition is a company based in Manchester (United Kingdom) founded in 2014. The company has 7 employees as of January 31, 2022. Chromition offers products and services including Luminspheres, DRACS, HER2 Detection, and CRISPR Detection. Chromition operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Manchester, United Kingdom
- Employees 7 as on 31 Jan, 2022
-
Sectors
TechnologyHealthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Chromition Limited
- Date of Incorporation 28 Nov, 2014
- Jurisdiction STOCKPORT, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$55.67 K (USD), Grant
May 31, 2019
-
Investors
Mercia
& 3 more
-
Employee Count
7
as on Jan 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Chromition
Chromition offers a comprehensive portfolio of products and services, including Luminspheres, DRACS, HER2 Detection, and CRISPR Detection.
Bright particles for simultaneous detection of multiple biological targets.
System for early cancer detection via blood sample analysis.
Ultra-sensitive method for identifying low-level HER2 in tissues.
Rapid tool for detecting target RNA at point of care.
Funding Insights of Chromition
Investors in Chromition
Chromition has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Mercia, European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Investment management services are provided by Mercia to various clients.
|
Locked | Locked | Locked |
Investor details for Chromition
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Chromition
Investment portfolio details for Chromition
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Chromition
Detailed financials for Chromition
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chromition Comparisons
Peer comparison for Chromition
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Chromition
Chromition operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Chromition
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chromition
Complete news archive for Chromition
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chromition
Chromition was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Chromition is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.
As of Jan 31, 2022, the latest employee count at Chromition is 7.
Chromition was founded in 2014 as a spin-out from the University of Manchester and is located in Manchester, United Kingdom. Nanoparticle technologies, including photoluminescent Luminspheres, semiconductor Elecspheres, and dielectric Dielecspheres, are developed for applications in bioimaging, anti-counterfeiting, lighting, detection, solar cells, sensors, and low-powered electronics. Patented Lumispheres particles are employed to bind with cancer cells for detection purposes.
Chromition's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Chromition offers Luminspheres, DRACS, HER2 Detection, and CRISPR Detection.
Chromition has 4 investors. Key investors include Mercia, European Union, EIC Fund, and SBRI Healthcare.